Inventor
PANOUSIS CON
AU18 patents
⚠️ This page may combine multiple inventors who share the name “PANOUSIS CON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CSL LTD
7 patentsUS10047161B2Aug 14, 2018
Humanized anti-interleukin 3 receptor alpha chain antibodies
CSL LTD2 citations72
US9758585B2Sep 12, 2017
Compositions and methods for targeting type 1 interferon producing cells
CSL LTD2 citations70
US11840573B2Dec 12, 2023
CD131 binding proteins and uses thereof
CSL LTD1 citations59
US11174321B2Nov 16, 2021
Method of treating atherosclerosis
CSL LTD1 citations57
US12071484B2Aug 27, 2024
Nucleic acids encoding antibodies against human granulocyte-colony stimulating factor receptor (G-CSFR) and method of expressing encoded protein
CSL LTD0 citations56
US11505619B2Nov 22, 2022
Use of a FXIIa-inhibitor in the treatment of renal fibrosis and/or chronic kidney disease
CSL LTD0 citations46
US11466073B2Oct 11, 2022
Human serum albumin variants and uses thereof
CSL LTD0 citations44
CSL BEHRING GMBH
4 patentsUS9856326B2Jan 2, 2018
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
CSL BEHRING GMBH9 citations83
US9856325B2Jan 2, 2018
Nucleic acids encoding inhibitory anti-factor XII/XIIa monoclonal antibodies
CSL BEHRING GMBH6 citations83
US10513560B2Dec 24, 2019
Methods of administering inhibitory anti-factor XII/XIIA monoclonal antibodies
CSL BEHRING GMBH1 citations72
US11345759B2May 31, 2022
Methods of administering inhibitory anti-factor XII/XIIa monoclonal antibodies
CSL BEHRING GMBH0 citations61
PANOUSIS CON
3 patentsUS9518127B2Dec 13, 2016
Inhibitory anti-factor XII/XIIA monoclonal antibodies and their uses
PANOUSIS CON8 citations81
US8569461B2Oct 29, 2013
Humanized anti-interleukin 3 receptor alpha chain antibodies
PANOUSIS CON5 citations81
US9617329B2Apr 11, 2017
Method of cloning nucleic acid
PANOUSIS CON0 citations48